Where I see patients (2)
My reviews
Selected research
-
BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib.
Blood
-
Absence of ABL1 exon 2-encoded SH3 residues in BCR::ABL1 destabilizes the autoinhibited kinase conformation and confers resistance to asciminib.
Leukemia
-
Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma.
JAMA network open
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421
5.0